Collegium to Present at Upcoming Investor Conferences

CANTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that management will present at the following investor conferences in June:

• The Jefferies Global Healthcare Conference on Thursday, June 7th at 9:30 a.m. ET in New York City
• The William Blair Growth Stock Conference on Wednesday, June 13th at 7:00 a.m. ET in Chicago

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company focused on becoming the leader in responsible pain management by developing and commercializing innovative, differentiated products for patients suffering from pain. 

About Xtampza ER

Xtampza® ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the FDA for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Contact: Alex Dasalla[email protected]

Source: Collegium Pharmaceutical, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FDA sets public hearing on psychedelics for September 14, Jefferies sees FDA willing to move on COMP360
• International Gaming Leader BOYLE Sports Chooses Jumio to Simplify Player Onboarding Across the UK and Ireland
• H1 2026 Operations Update